Longstaff C, Gaffney P J
National Institute for Biological Standards and Control, South Mimms, Herts, U.K.
Biochemistry. 1991 Jan 29;30(4):979-86. doi: 10.1021/bi00218a014.
We have examined in detail the kinetics of binding of the serpin alpha 2-antiplasmin to the serine proteases alpha-chymotrypsin and plasmin. These represent model systems for serpin binding. We find, in contrast to earlier published results with alpha 2-antiplasmin and plasmin, that binding is reversible, and slow binding kinetics can be observed, under appropriate conditions. Binding follows a two-step process with both enzymes, with the formation of an initial loose complex which then proceeds to a tightly bound complex. In the absence of lysine and analogues, equilibrium between alpha 2-antiplasmin and plasmin is achieved rapidly, with an overall inhibition constant (Ki') of 0.3 pM. In the presence of tranexamic acid or 6-aminohexanoic acid, lysine analogues that mimic the effects of fibrin, plasmin binding kinetics are changed such that equilibrium is reached slowly following a lag phase after mixing of enzyme and inhibitor. The Ki' is also affected, rising to 2 pM in the presence of 6-aminohexanoic acid concentrations above 15 mM. Thus extrapolation to the in vivo situation indicates that complex formation in the presence of fibrin will be delayed, allowing a burst of enzyme activity following plasmin generation, but a tight, pseudoirreversible complex will result eventually. Chymotrypsin is more weakly inhibited by alpha 2-antiplasmin, exhibiting an overall Ki' of 0.1 nM, after two-stage complex formation. The inhibition constant for the initial loose complex (Ki) is very similar for both enzymes. The difference in binding strength between the two enzymes is accounted for by the dissociation rate constant of the second step of complex formation.(ABSTRACT TRUNCATED AT 250 WORDS)
我们详细研究了丝氨酸蛋白酶抑制剂α2-抗纤溶酶与丝氨酸蛋白酶α-糜蛋白酶和纤溶酶结合的动力学。这些代表了丝氨酸蛋白酶抑制剂结合的模型系统。我们发现,与早期发表的关于α2-抗纤溶酶和纤溶酶的结果相反,在适当条件下,结合是可逆的,并且可以观察到缓慢的结合动力学。两种酶的结合都遵循两步过程,首先形成初始的松散复合物,然后发展为紧密结合的复合物。在没有赖氨酸及其类似物的情况下,α2-抗纤溶酶和纤溶酶之间能迅速达到平衡,总体抑制常数(Ki')为0.3 pM。在氨甲环酸或6-氨基己酸(模拟纤维蛋白作用的赖氨酸类似物)存在的情况下,纤溶酶结合动力学发生变化,使得在酶和抑制剂混合后的延迟期后缓慢达到平衡。Ki'也受到影响,当6-氨基己酸浓度高于15 mM时,Ki'升至2 pM。因此,推断体内情况表明,在纤维蛋白存在下复合物的形成将被延迟,使得纤溶酶产生后会有一阵酶活性爆发,但最终会形成紧密的、假不可逆的复合物。α2-抗纤溶酶对α-糜蛋白酶的抑制作用较弱,在两阶段复合物形成后,总体Ki'为0.1 nM。两种酶初始松散复合物的抑制常数(Ki)非常相似。两种酶结合强度的差异是由复合物形成第二步的解离速率常数造成的。(摘要截取自250字)